ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1042

IL-1β and TNF-α Promote Monocyte Viability through the Induction of GM-CSF Expression By Rheumatoid Arthritis Synovial Fibroblasts

Christelle Darrieutort-Laffite1,2, Marie Astrid Boutet1, Mathias Chatelais1, Regis Brion3, Frederic Blanchard1, Dominique Heymann3 and Benoit Le Goff1,2, 1Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, INSERM, UMR 957, Nantes, France, 2Rheumatology, Nantes University Hospital, Nantes, France, 3Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes, INSERM, UMR 957, Nantes, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: IL-1, monocytes, Rheumatoid arthritis (RA), synovial cells, synovial fluid and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Macrophages and synovial fibroblasts (SF) are two major cells implicated in the pathogenesis of rheumatoid arthritis (RA). They can interact in the synovial micro-environment to drive inflammation and bone destruction. The aim of our work was to investigate the effects of SF on monocyte viability and differentiation and to determine which factors were implicated in these effects.

Methods

SF were isolated from synovial tissue of 9 RA patients and CD14+ cells were magnetically isolated from healthy donors by MACS technology. SF conditioned media were collected after 24 hours of culture with or without TNF-α or IL-1β. After 3 days of culture with RA SF conditioned media, monocyte survival was assessed using a WST-1 viability test. To study the involvement of M-CSF, IL-34 and GM-CSF, their expression was quantified in RA SF by qPCR, in RA synovial fluids by ELISA assay, and specific blocking antibodies were used in monocyte cultures. Macrophages polarization after culture with RA SF conditioned media was studied by flow cytometry. The cell surface markers analyzed were CD14, CD16, CD64 (M1), CD200R (M2a) and CD163 (M2c). A non-parametric test (Kruskall Wallis) was used to perform statistical analyzes.

Results

SF conditioned media significantly increased monocyte viability compared to cells cultured in medium alone (p<0.001). This effect was stronger when using conditioned media from IL-1β or TNF-α pre-stimulated SF. Monocyte viability was significantly increased compared to M-CSF (+29% (p=0.05) and +52% (p=0.004) for TNF-α and IL-1-β media respectively). M-CSF and IL-34 blocking antibodies, alone and in combination, had no effect on monocyte viability induced by SF conditioned media. In contrast, blocking GM-CSF resulted in a significant decrease in monocyte viability by 30% when added to the stimulated SF conditioned media (p<0.001). The expression of GM-CSF by RA SF was stimulated by TNF-α and IL-1β and GM-CSF levels in the synovial fluids were correlated with those of these two cytokines. Finally, studying the cell surface markers, we found no regulation of M1/M2 polarization when monocytes were differentiated in the presence of SF conditioned media.

Conclusion

SF conditioned media increased monocyte viability with a greater effect observed when SF were pre-stimulated with IL-1β or TNF-α and this effect was GM-CSF-dependent. However, cells cultured in the presence of conditioned media did not express specific M1 or M2 markers.


Disclosure:

C. Darrieutort-Laffite,
None;

M. A. Boutet,
None;

M. Chatelais,
None;

R. Brion,
None;

F. Blanchard,
None;

D. Heymann,
None;

B. Le Goff,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-1%ce%b2-and-tnf-%ce%b1-promote-monocyte-viability-through-the-induction-of-gm-csf-expression-by-rheumatoid-arthritis-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology